Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RNAZ

TransCode Therapeutics Inc

May 28 • 02:50PM ET

5.32

+0.22 4.42 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: LNAI APRE BCDA BIVI CALC CVM GOVX KAPA KPRX NEUP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-48.65	Insider Own	9.08%	Shs Outstand	0.92M	Perf Week	-13.01%
Market Cap	5.05M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.86M	Perf Month	-37.10%
Enterprise Value	135.48M	PEG	-	EPS next Q	-	Inst Own	7.63%	Short Float	4.22%	Perf Quarter	-47.74%
Income	-43.70M	P/S	-	EPS this Y	-	Inst Trans	2.95%	Short Ratio	3.94	Perf Half Y	-41.27%
Sales	0.00M	P/B	3.89	EPS next Y	-	ROA	-47.38%	Short Interest	0.04M	Perf YTD	-22.18%
Book/sh	1.36	P/C	0.39	EPS next 5Y	-	ROE	-52.14%	52W High	20.99 -74.68%	Perf Year	-23.74%
Cash/sh	13.50	P/FCF	-	EPS past 3/5Y	96.25% 79.17%	ROIC	-27.93%	52W Low	5.01 6.09%	Perf 3Y	-100.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	11.80% 9.65%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	95.40%	Oper. Margin	-	ATR (14)	0.66	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.11	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	23.45	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.11	EPS Q/Q	69.67%	SMA20	-21.04%	Beta	1.32	Target Price	280.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-33.09%	Rel Volume	2.41	Prev Close	5.09
Employees	12	LT Debt/Eq	0.00	Earnings	-	SMA200	-44.29%	Avg Volume	9.20K	Price	5.32
IPO	Jul 09, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	67.35% -100.00%	Trades		Volume	19,326	Change	4.42%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)